Mirae Asset Global Investments
TYRA icon

Mirae Asset Global Investments’s Tyra Biosciences TYRA Stock Holding History

Mirae Asset Global Investments’s Portfolio TYRA Stock Details TYRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$85K Sell
2,660
-124
-4% -$4.1K ﹤0.01% 1271
2026
Q1 		$107K Buy
2,784
+190
+7% +$6.15K ﹤0.01% 1168
2025
Q4 		$68.2K Buy
2,594
+534
+26% +$9.81K ﹤0.01% 1338
2025
Q3 		$28.8K Buy
2,060
+6
+0.3% +$68 ﹤0.01% 1443
2025
Q2 		$19.7K Buy
2,054
+361
+21% +$3.43K ﹤0.01% 1401
2025
Q1 		$16.5K Buy
1,693
+7
+0.4% +$91 ﹤0.01% 1404
2024
Q4 		$23.7K Buy
+1,686
New +$30.6K ﹤0.01% 1395

Other funds holding TYRA

APMC
Alta Partners Management Company Jackson, Wyoming $127M AUM 230.85% 1-Year Est. Return
CPX
Canaan Partners XI Menlo Park, California $127M AUM 217.49% 1-Year Est. Return
TE
Tema ETFs New York $3.09B AUM 72.72% 1-Year Est. Return
AI
Auour Investments Woburn, Massachusetts $349M AUM 13.68% 1-Year Est. Return
PFSRSONJ
Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return
CUAMC
China Universal Asset Management Company Shanghai, China $1.67B AUM 89% 1-Year Est. Return
VCM
Versant Capital Management Phoenix, Arizona $1.12B AUM 34.21% 1-Year Est. Return
GI
GAMMA Investing Foster City, California $2.69B AUM 42.78% 1-Year Est. Return
TWD
True Wealth Design Akron, Ohio $420M AUM 22.7% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $12.8B AUM 26.53% 1-Year Est. Return

Mirae Asset Global Investments's TYRA Position: Q2 2026 in Review

Mirae Asset Global Investments reduced its Tyra Biosciences (TYRA) stake by 4.5% in Q2 2026, selling an estimated $4.1K and leaving 2,660 shares worth $85K. The position accounts for ﹤0.01% of the portfolio, ranked #1271.

Mirae Asset Global Investments first reported a position in TYRA in Q4 2024 and has held it in 7 quarters since. The position peaked at $107K in Q1 2026. 16 funds tracked by Wall St. Rank hold TYRA as of Q2 2026.

  • Mirae Asset Global Investments held 2,660 shares of Tyra Biosciences worth $85K as of Q2 2026.
  • Mirae Asset Global Investments sold 124 Tyra Biosciences shares in Q2 2026, an estimated $4.1K.
  • Tyra Biosciences made up ﹤0.01% of Mirae Asset Global Investments's portfolio in Q2 2026, its #1271 holding.
  • Mirae Asset Global Investments first reported a position in Tyra Biosciences in Q4 2024 and has held it in 7 quarters since.
  • Mirae Asset Global Investments's Tyra Biosciences position peaked at $107K in Q1 2026.
  • 16 funds tracked by Wall St. Rank held Tyra Biosciences as of Q2 2026.

Based on Mirae Asset Global Investments's 13F filing for Q2 2026, filed 22 Jul 2026.